Supplemention of maternal diet
View Patent ↗The use of probiotic bacteria in the manufacture of a composition for administration to a woman in at least the third trimester of pregnancy for prevention of gestational diabetes, normalizing plasma glucose concentration and/or increasing insulin sensitivity.
1. A method for reducing the risk of developing gestational diabetes comprising administering to a woman in at least the third trimester of pregnancy in need thereof, a therapeutically-effective amount of a composition comprising probiotic bacteria Lactobacillus rhamnosus ATCC 53103 and Bifidobacterium lactis CNCM I-3446.
2. The method of claim 1 , wherein administration of the composition continues after delivery.
3. The method of claim 1 , wherein the probiotic bacteria is administered in a daily dose of between 10 5 to 10 12 colony forming units.
4. The method of claim 1 , wherein the probiotic bacteria is administered to the woman for the second and third trimesters of pregnancy.
5. The method of claim 1 , wherein the probiotic bacteria is administered for the full duration of the pregnancy.
6. The method of claim 1 , wherein the probiotic bacteria is administered in a daily dose of between 10 7 to 10 11 colony foaming units.
7. The method of claim 1 , wherein the composition further comprises a fat source that provides 20% to 30% of the total energy of the composition, a carbohydrate source that provides 40% to 80% of the total energy of the composition, and a protein source.
8. The method of claim 1 , wherein the woman to whom the composition is administered has a characteristic indicating increased risk of gestational diabetes, the characteristic selected from the group consisting of a pre-pregnancy body mass index over 25, an age over 40 years, gestational diabetes mellitus during a previous pregnancy, a previous delivery of a child who weighed more than 4500 g, detection of glucose in urine, suspect of macrosomic fetus in present pregnancy, and combinations thereof.